|
PSMA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.891000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.347240E-01 |
| Normal-vs-Stage2 |
7.749000E-01 |
| Normal-vs-Stage3 |
9.936600E-01 |
| Normal-vs-Stage4 |
5.224000E-01 |
| Stage1-vs-Stage2 |
4.067000E-01 |
| Stage1-vs-Stage3 |
1.141630E-01 |
| Stage1-vs-Stage4 |
6.457700E-02 |
| Stage2-vs-Stage3 |
7.544000E-01 |
| Stage2-vs-Stage4 |
4.169600E-01 |
| Stage3-vs-Stage4 |
4.888000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.680000E-01 |
| Normal-vs-AfricanAmerican |
5.077800E-01 |
| Normal-vs-Asian |
4.320200E-01 |
| Caucasian-vs-AfricanAmerican |
3.069000E-01 |
| Caucasian-vs-Asian |
8.059400E-01 |
| AfricanAmerican-vs-Asian |
2.101200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.701600E-01 |
| Normal-vs-Female |
2.830800E-01 |
| Male-vs-Female |
3.223200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.193970E-01 |
| Normal-vs-Age(41-60Yrs) |
9.411400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.602800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.840600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.037800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.709700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.079800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.514400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.351800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.262400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.387800E-01 |
| Classical-VS-Follicular |
5.916800E-01 |
| Classical-VS-Other |
4.213400E-01 |
| Classical-VS-Normal |
3.525400E-01 |
| Tall-VS-Follicular |
8.044400E-01 |
| Tall-VS-Other |
6.977400E-01 |
| Tall-VS-Normal |
9.708000E-01 |
| Follicular-VS-Other |
7.035200E-01 |
| Follicular-VS-Normal |
8.010200E-01 |
| Other-VS-Normal |
6.402800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.255400E-01 |
| Normal-vs-N1 |
6.631600E-01 |
| N0-vs-N1 |
7.518600E-01 |
|
|
